Clinical outcomes are worse in patients with coronary artery bifurcation lesions, even if commonly encountered in clinical practice. The use of drug coated balloons within bifurcation lesions offers the acute advantage of a more straightforward procedure, without recrossing and deformation of a stent. Thus, the primary objective of this study is to determine if Drug Coated Balloon treatment of non-left main true coronary artery bifurcation lesions is non-inferior (similar) to a provisional strategy with Drug Eluted Stent deployment.
True non-left main bifurcation disease with both MV and SB involvement (i.e Medina 1/1/1, 1/0/1, 0/1/1)
≥70% angiographic MV and SB diameter stenosis
Positive non-invasive testing for ischaemia
Positive coronary physiology for ischaemia
Patients <18 years old
STEMI <48 hours
Cardiogenic shock
Chronic total occlusion involving target bifurcation vessels
Ceric Sàrl
Lead sponsor
European Cardiovascular Research Center
Collaborator